Nationwide Fund Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,118
Closed -$290K 2670
2017
Q3
$290K Sell
2,118
-88
-4% -$11.8K ﹤0.01% 2451
2017
Q2
$315K Sell
2,206
-825
-27% -$127K ﹤0.01% 2420
2017
Q1
$557K Buy
3,031
+1,810
+148% +$203K ﹤0.01% 2106
2016
Q4
$98K Buy
1,221
+16
+1% +$1.27K ﹤0.01% 2884
2016
Q3
$92K Hold
1,205
﹤0.01% 2920
2016
Q2
$104K Hold
1,205
﹤0.01% 2903
2016
Q1
$112K Hold
1,205
﹤0.01% 2773
2015
Q4
$242K Buy
1,205
+35
+3% +$6.98K ﹤0.01% 2447
2015
Q3
$175K Sell
1,170
-904
-44% -$663K ﹤0.01% 2633
2015
Q2
$1.97M Buy
2,074
+1,050
+103% +$859K 0.01% 1435
2015
Q1
$751K Buy
1,024
+41
+4% +$30.8K ﹤0.01% 2040
2014
Q4
$781K Buy
983
+141
+17% +$75.9K ﹤0.01% 1933
2014
Q3
$336K Buy
842
+4
+0.5% +$1.07K ﹤0.01% 2441
2014
Q2
$226K Buy
838
+303
+57% +$65K ﹤0.01% 2687
2014
Q1
$117K Hold
535
﹤0.01% 2704
2013
Q4
$145K Buy
535
+77
+17% +$18.4K ﹤0.01% 2829
2013
Q3
$104K Buy
458
+277
+153% +$48.4K ﹤0.01% 2924
2013
Q2
$25K Buy
+181
New +$28.7K ﹤0.01% 3069

Other funds holding TTPH

Nationwide Fund Advisors's TTPH Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2017, closing a stake of 2,118 shares — an estimated $290K sold.

Nationwide Fund Advisors first reported a position in TTPH in Q2 2013 and held it in 18 quarters. The position peaked at $1.97M in Q2 2015. 103 funds tracked by Wall St. Rank hold TTPH as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 2,118 Tetraphase Pharmaceuticals, Inc. shares in Q4 2017, an estimated $290K.
  • Nationwide Fund Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $1.97M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.